Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
9
CHEB Quote, Financials, Valuation and Earnings
Last price:
$10.10
Seasonality move
:
--
Day range:
$10.06 - $10.08
52-week range:
$9.96 - $10.10
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.45x
Volume:
19.1K
Avg. volume:
60.8K
1-year change:
--
Market cap:
$118.8M
Revenue:
--
EPS (TTM):
--
Earnings Data
Next earnings date for CHEB
Feb 28
2025
Most recent earnings per share
-$0.12
Missed by $0.12
(Nov 14/2024)
Consensus Estimate
--
(Nov 14/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
CHEB Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 11/14/2024 | Q3 | -- | -- | -$0.12 | -- | -- |
| 08/14/2024 | Q2 | -- | -- | -$0.10 | -- | -- |
| 03/31/2024 | Q1 | -- | -- | -$0.01 | -- | -- |
Chenghe Acquisition II Earnings Questions
-
How Much did Chenghe Acquisition II Generate in Revenue Last Quarter?
Chenghe Acquisition II reported -- worth of top line sales in its most recent quarter.
-
Did Chenghe Acquisition II Beat Earnings Last Quarter?
Chenghe Acquisition II announced earnings per share of -$0.12 which represents a miss of analyst forecast a -- per share.
-
Is Chenghe Acquisition II Profitable?
Chenghe Acquisition II reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Chenghe Acquisition II EPS Next Year?
Chenghe Acquisition II's earnings are forecast to grow from -- per share to -- per share next year representing an increase of --.
-
When is Chenghe Acquisition II's Earnings Date?
Chenghe Acquisition II's next earnings date is February 28, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
